Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01038414
Other study ID # 5R01DA12165-8
Secondary ID 5R01DA012165
Status Recruiting
Phase Phase 4
First received December 22, 2009
Last updated June 22, 2011
Start date February 2008
Est. completion date January 2013

Study information

Verified date June 2011
Source Harvard University Faculty of Medicine
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if extending the behavioral smoking-cessation treatment period to one year will significantly improve cessation outcomes among those planning a quit attempt.


Recruitment information / eligibility

Status Recruiting
Enrollment 450
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Daily Cigarette Smokers

Exclusion Criteria:

- Smokers with active atherosclerotic heart disease, severe cardiac arrhythmias, uncontrolled hypertension, severe peripheral vascular disease, pre-controlled diabetes mellitus, pregnancy, lactation or likely to become pregnant during the study period, and chronic dermatologic disease.

- Smokers who meet DSM-IV lifetime criteria for conditions such as schizo-affective disorder and schizophrenia, bi-polar disorder, or who have had alcohol or drug dependence issues within the past year.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Extended Duration Behavioral Smoking Cessation Counseling
Subjects are randomized to one of 3 behavioral treatments: (1) Brief Duration (3 month) smoking-cessation counseling; (2) Moderate Duration (6 month) counseling; or (3) Extended Duration (12 month) counseling

Locations

Country Name City State
United States Harvard School of Dental Medicine Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Harvard University Faculty of Medicine National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of subjects abstinent by treatment group at 1 year post-cessation. One year No
Secondary Proportion of subjects abstinent by treatment group at 2 years post-cessation. Two years No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02544360 - A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools N/A
Completed NCT00491335 - HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers N/A
Completed NCT02124200 - High Cessation Rates in Smokers Using Personal Vaporizers Phase 4
Completed NCT01785147 - Efficacy and Safety of BP1.4979 in Smoking Cessation Phase 2
Completed NCT02000921 - Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors N/A